已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Efficacy and safety of loxoprofen sodium topical patch for the treatment of pain in patients with minor acute traumatic limb injuries in Brazil: a randomized, double-blind, noninferiority trial

医学 不利影响 可视模拟标度 非甾体 随机对照试验 临床试验 双盲 麻醉 内科学 安慰剂 病理 替代医学
作者
Edison Noboru Fujiki,Nicola Archetti Netto,Durval Campos Kraychete,Murilo Tavares Daher,Ricardo Tardini,Allyson Nakamoto,Danilo Lopes
出处
期刊:Pain [Lippincott Williams & Wilkins]
卷期号:160 (7): 1606-1613 被引量:9
标识
DOI:10.1097/j.pain.0000000000001549
摘要

Posttraumatic injury pain is commonly treated with oral nonsteroidal anti-inflammatory drugs. However, oral nonsteroidal anti-inflammatory drugs cause several adverse events, with topical formulations arising as an important alternative. Therefore, we aimed at evaluating the efficacy and safety of loxoprofen patch (LX-P) in the treatment of patients with posttraumatic pain. This phase III, randomized, double-blind, noninferiority study enrolled Brazilian patients aged 18 to 65 years diagnosed with lower and upper limb posttraumatic injury who were experiencing moderate or severe pain. Patients were assigned to active LX-P or to loxoprofen tablet (LX-T), and pain intensity was measured based on a visual analog scale score variation after 7 days of treatment. Data on clinical symptoms, rescue medication use, and adverse events were also collected. Visual analog scale score variation was compared using a 10% noninferiority margin. Two hundred forty-two patients were randomly assigned to LX-P (n = 123) or to LX-T (n = 119). The results showed a reduction in pain after 7 days of treatment: -49.96 (n = 118; SE 1.7) in the LX-P and -47.71 (n = 117; SE 1.6) in the LX-T groups (difference of -2.25; 95% CI: -5.97 to 1.47; P = 0.23). On the safety analysis, the LX-T group presented twice as many patients with treatment-emergent adverse events as the LX-P group (30.8% and 14.2%, respectively). A sensitivity analysis demonstrated that rescue medication use has not affected the primary end point. This study showed that LX-P has a comparable efficacy to LX-T, but with a better safety profile, being a therapeutic option for the treatment of posttraumatic injury pain.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
王涛发布了新的文献求助10
1秒前
lin发布了新的文献求助10
1秒前
秋风的应助被哆米采纳,获得20
1秒前
ARIA完成签到,获得积分10
1秒前
郭小兰完成签到,获得积分10
1秒前
1秒前
灵巧的松思完成签到 ,获得积分10
2秒前
研友_ZGXj48完成签到 ,获得积分20
4秒前
huifeideyu发布了新的文献求助10
5秒前
uzumay完成签到,获得积分10
6秒前
7秒前
yufu发布了新的文献求助50
9秒前
9秒前
黄jw完成签到 ,获得积分10
10秒前
文艺的早晨完成签到 ,获得积分10
11秒前
研友_VZG7GZ的应助被小玲子采纳,获得10
12秒前
AccompanyX发布了新的文献求助10
14秒前
爱笑楼房完成签到,获得积分10
14秒前
所所的应助被冷酷的水壶采纳,获得10
15秒前
Hoda的应助被automan采纳,获得10
15秒前
bkagyin的应助被嗦了一碗粉采纳,获得10
15秒前
一一完成签到 ,获得积分10
15秒前
16秒前
有病早治完成签到 ,获得积分10
16秒前
chiyudawang发布了新的文献求助10
17秒前
17秒前
情怀的应助被wonderfulwisdom采纳,获得10
17秒前
17秒前
时间完成签到,获得积分10
18秒前
喻喻喻同志完成签到 ,获得积分10
20秒前
21秒前
21秒前
风吹麦浪的应助被Gibson采纳,获得10
21秒前
22秒前
leegawei发布了新的文献求助10
22秒前
Akim的应助被rain采纳,获得10
23秒前
yangx完成签到,获得积分10
24秒前
英姑的应助被秃头泡泡采纳,获得10
24秒前
25秒前
123发布了新的文献求助10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179198
求助须知:如何正确求助?哪些是违规求助? 9569781
关于积分的说明 21806509
捐赠科研通 7774542
什么是DOI,文献DOI怎么找? 3433008
关于科研通互助平台的介绍 2556929
邀请新用户注册赠送积分活动 2478652